Literature DB >> 33175491

Structural Insight into the DNA Binding Function of Transcription Factor ERF.

Caixia Hou1, Claudia McCown2, Dmitri N Ivanov2, Oleg V Tsodikov1.   

Abstract

ETS family transcription factors control development of different cell types in humans, whereas deregulation of these proteins leads to severe developmental syndromes and cancers. One of a few members of the ETS family that are known to act solely as repressors, ERF, is required for normal osteogenesis and hematopoiesis. Another important function of ERF is acting as a tumor suppressor by antagonizing oncogenic fusions involving other ETS family factors. The structure of ERF and the DNA binding properties specific to this protein have not been elucidated. In this study, we determined two crystal structures of the complexes of the DNA binding domain of ERF with DNA. In one, ERF is in a distinct dimeric form, with Cys72 in a reduced state. In the other, two dimers of ERF are assembled into a tetramer that is additionally locked by two Cys72-Cys72 disulfide bonds across the dimers. In the tetramer, the ERF molecules are bound to a pseudocontinuous DNA on the same DNA face at two GGAA binding sites on opposite strands. Sedimentation velocity analysis showed that this tetrameric assembly forms on continuous DNA containing such tandem sites spaced by 7 bp. Our bioinformatic analysis of three previously reported sets of ERF binding loci across entire genomes showed that these loci were enriched in such 7 bp spaced tandem sites. Taken together, these results strongly suggest that the observed tetrameric assembly is a functional state of ERF in the human cell.

Entities:  

Year:  2020        PMID: 33175491      PMCID: PMC8110599          DOI: 10.1021/acs.biochem.0c00774

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  45 in total

1.  ERF nuclear shuttling, a continuous monitor of Erk activity that links it to cell cycle progression.

Authors:  Lionel Le Gallic; Laura Virgilio; Philip Cohen; Benoit Biteau; George Mavrothalassitis
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

2.  Structural analysis of the autoinhibition of Ets-1 and its role in protein partnerships.

Authors:  Colin W Garvie; Miles A Pufall; Barbara J Graves; Cynthia Wolberger
Journal:  J Biol Chem       Date:  2002-09-06       Impact factor: 5.157

3.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

4.  A novel modulator domain of Ets transcription factors.

Authors:  C Wasylyk; J P Kerckaert; B Wasylyk
Journal:  Genes Dev       Date:  1992-06       Impact factor: 11.361

5.  Suppression of Fgf2 by ETS2 repressor factor (ERF) is required for chorionic trophoblast differentiation.

Authors:  Elena Vorgia; Andreas Zaragkoulias; Ioanna Peraki; George Mavrothalassitis
Journal:  Mol Reprod Dev       Date:  2017-02-28       Impact factor: 2.609

6.  Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybrids.

Authors:  M Athanasiou; L LeGallic; D K Watson; D G Blair; G Mavrothalassitis
Journal:  Cancer Gene Ther       Date:  2000-08       Impact factor: 5.987

7.  Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo.

Authors:  Gong-Hong Wei; Gwenael Badis; Michael F Berger; Teemu Kivioja; Kimmo Palin; Martin Enge; Martin Bonke; Arttu Jolma; Markku Varjosalo; Andrew R Gehrke; Jian Yan; Shaheynoor Talukder; Mikko Turunen; Mikko Taipale; Hendrik G Stunnenberg; Esko Ukkonen; Timothy R Hughes; Martha L Bulyk; Jussi Taipale
Journal:  EMBO J       Date:  2010-06-01       Impact factor: 11.598

8.  Crystal structure of the lactose operon repressor and its complexes with DNA and inducer.

Authors:  M Lewis; G Chang; N C Horton; M A Kercher; H C Pace; M A Schumacher; R G Brennan; P Lu
Journal:  Science       Date:  1996-03-01       Impact factor: 47.728

9.  A two-dimensional spectrum analysis for sedimentation velocity experiments of mixtures with heterogeneity in molecular weight and shape.

Authors:  Emre Brookes; Weiming Cao; Borries Demeler
Journal:  Eur Biophys J       Date:  2009-02-27       Impact factor: 1.733

10.  Reduced dosage of ERF causes complex craniosynostosis in humans and mice and links ERK1/2 signaling to regulation of osteogenesis.

Authors:  Stephen R F Twigg; Elena Vorgia; Simon J McGowan; Ioanna Peraki; Aimée L Fenwick; Vikram P Sharma; Maryline Allegra; Andreas Zaragkoulias; Elham Sadighi Akha; Samantha J L Knight; Helen Lord; Tracy Lester; Louise Izatt; Anne K Lampe; Shehla N Mohammed; Fiona J Stewart; Alain Verloes; Louise C Wilson; Chris Healy; Paul T Sharpe; Peter Hammond; Jim Hughes; Stephen Taylor; David Johnson; Steven A Wall; George Mavrothalassitis; Andrew O M Wilkie
Journal:  Nat Genet       Date:  2013-01-27       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.